Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering

Expert Opinion on Drug Delivery
Dmitri A Ossipov

Abstract

Bisphosphonates (BPs) were introduced 45 years ago as anti-osteoporotic drugs and during the last decade have been utilized as bone-targeting groups in systemic treatment of bone diseases. Very recently, strategies of chemical immobilization of BPs in hydrogels and nanocomposites for bone tissue engineering emerged. These strategies opened new applications of BPs in bone tissue engineering. Conjugates of BPs to different drug molecules, imaging agents, proteins and polymers are discussed in terms of specific targeting to bone and therapeutic affect induced by the resulting prodrugs in comparison with the parent drugs. Conversion of these conjugates into hydrogel scaffolds is also presented along with the application of the resulting materials for bone tissue engineering. Calcium-binding properties of BPs can be successfully extended via different conjugation strategies not only for purposes of bone targeting, but also in supramolecular assembly affording either new nanocarriers or bulk nanocomposite scaffolds. Interaction between carrier-linked BPs and drug molecules should also be considered for the control of release of these molecules and their optimized delivery. Bone-targeting properties of BP-functionalized nanomaterials ...Continue Reading

References

Nov 3, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S P LuckmanM J Rogers
Jul 10, 1999·Bioorganic & Medicinal Chemistry·L GilR N Young
Apr 8, 2000·Biotechnology Progress·H UludagD Kantoci
Aug 21, 2001·The Journal of Organic Chemistry·S RensingT Schrader
Jun 22, 2002·Lancet·Pierre D Delmas
Jul 21, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sébastien A GittensHasan Uludag
Nov 25, 2005·Journal of the American Chemical Society·Vojtech KubícekIvan Lukes
Dec 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ilia FishbeinRobert J Levy
Jan 13, 2006·Journal of the American Chemical Society·Christian RennerThomas Schrader
Oct 3, 2006·Chemical Communications : Chem Comm·Ling WangBing Xu
May 29, 2007·Biomacromolecules·Matthew B MurphyAntonios G Mikos
Jul 14, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sung-Wook Choi, Jung-Hyun Kim
Aug 21, 2007·Bioconjugate Chemistry·Dong WangJindrich Kopecek
Sep 18, 2007·Angewandte Chemie·Kumar R BhushanJohn V Frangioni
Nov 16, 2007·Bioconjugate Chemistry·Robin S EhrickLeonidas G Bachas
Dec 7, 2007·Bioorganic & Medicinal Chemistry Letters·Rotem ErezDoron Shabat
May 29, 2008·Chemical Communications : Chem Comm·Yoann LalatonneLaurence Motte
Nov 27, 2008·Bioconjugate Chemistry·Boris A KashemirovCharles E McKenna
Feb 24, 2009·Acta Orthopaedica·Per Aspenberg
Apr 15, 2010·Bioconjugate Chemistry·Rafael Torres Martin de RosalesPhilip J Blower
Jul 29, 2010·International Journal of Oncology·Anders R HolmbergSten Nilsson
Nov 30, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Elisabeth V GigerJean-Christophe Leroux
Dec 15, 2010·Bone·Philippe ClézardinPeter I Croucher
Jan 25, 2011·Bone·J Mark Wilkinson, David G Little
Feb 23, 2011·Bioconjugate Chemistry·Rafael Torres Martin de RosalesPhilip J Blower
May 11, 2011·Bone·R Graham G Russell

❮ Previous
Next ❯

Citations

Mar 5, 2016·Matrix Biology : Journal of the International Society for Matrix Biology·Andrew S CurrySusan L Bellis
Feb 19, 2016·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Saber GhadakzadehMaryam Tabrizian
Feb 17, 2017·Advanced Healthcare Materials·Robin A NadarSander C G Leeuwenburgh
Jun 24, 2017·International Journal of Molecular Sciences·Molly StapletonShunji Tomatsu
Sep 26, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Vuk UskokovićVictoria M Wu
Nov 7, 2019·Advanced Healthcare Materials·Yutao CuiJianxun Ding
Dec 16, 2018·Pharmaceutics·Patricia Diaz-RodriguezMariana Landin
Jun 8, 2017·Drug Delivery and Translational Research·Jacqueline CawthrayKishor Wasan
Aug 14, 2019·Journal of Biomedical Materials Research. Part a·Nicholas W PensaSusan L Bellis
Jun 19, 2020·BioMed Research International·Yuzhou LiSheng Yang
Nov 8, 2020·Journal of Materials Science. Materials in Medicine·Carolina Simão AlbanoPaulo Noronha Lisboa-Filho
Jan 12, 2020·Pharmacology & Therapeutics·Chen ShiDehao Fu
Dec 31, 2020·Tissue Engineering. Part B, Reviews·Daniela Geta Petre, Sander C G Leeuwenburgh
Jul 9, 2020·Bioactive Materials·Weihao YuanLiming Bian
Jul 3, 2021·International Journal of Molecular Sciences·Zintle Mbese, Blessing A Aderibigbe
Apr 19, 2016·Bioconjugate Chemistry·Evan M PeckBradley D Smith
May 13, 2019·ACS Biomaterials Science & Engineering·Elham HatamiMurali Mohan Yallapu
Sep 3, 2021·Journal of Pharmaceutical Sciences·Debyashreeta BarikMamoni Dash

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmaceutical Research
Elizabeth Cosgriff-Hernandez, Antonios G Mikos
Journal of Controlled Release : Official Journal of the Controlled Release Society
Roberta CensiWim E Hennink
Pharmaceutics
Nicolas AntonThierry F Vandamme
Expert Opinion on Drug Delivery
Mohd Cairul Iqbal Mohd AminNajwa Mohamad
© 2022 Meta ULC. All rights reserved